Organon & Co.

OGNNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.592 B

$13.68 +0.00%

Close of 21 Sept 2026

Revenue

$6.22B

#580 by revenue

Earnings

$187.0M

#1034 by earnings

Shares outstanding

262,609,433

Latest filing cover page

P/E ratio

19.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#68IDEAYA BiosciencesIDYA$3.75B
#69Legend BiotechLEGN$3.60B
#70Organon & Co.OGN$3.59B
#71Enliven TherapeuticsELVN$3.58B
#72Viking TherapeuticsVKTX$3.51B

What if Organon & Co. were worth as much as…

Open the what-if tool →

Gold $30.3T

$115,281.67

Per share 8,427× higher

Bitcoin $1.72T

$6,548.90

Per share 479× higher

Nvidia $5.48T

$20,866.95

Per share 1,525× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Organon & Co. are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.